Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Cancer & Clinical Oncology|April 1, 1988
Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in ratsR Gerritsen van der Hoop, P de Koning, E Boven, et al.
British Journal of Cancer|October 1, 1996
Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneouslyA H Honkoop, K Hoekman, J Wagstaff, et al.
British Journal of Cancer|September 1, 1992
A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancerH J Haisma, E Boven, M van Muijen, et al.
British Journal of Cancer|January 1, 1997
Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of carboplatin in miceA E Korst, E Boven, M L van der Sterre, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenograftsV W Ruiz van Haperen, G Veerman, B J Braakhuis, et al.
British Journal of Cancer|December 23, 1998
The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenograftsP H Houba, E Boven, C A Erkelens, et al.
Cancer Research|November 1, 1992
Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative studyE Boven, B Winograd, D P Berger, et al.
International Journal of Cancer|June 9, 1995
Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenograftsH J Broxterman, N Feller, C M Kuiper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up studyS P Langdon, H R Hendriks, B J Braakhuis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patientsA H Honkoop, K Hoekman, J Wagstaff, et al.
Pageof 13